4imprint Group PLC
04 September 2007
For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: Notifications of Major Interests in Shares
1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached:
4imprint Group PLC
2. Reason for notification
(please place an X inside the appropriate bracket/s):
An acquisition or disposal of voting rights: (Yes)
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached: ( )
An event changing the breakdown of voting rights: ( )
Other (please specify) : ( )
3. Full name of person(s) subject to notification obligation:
Aberforth Partners LLP
4. Full name of shareholder(s) (if different from 3) :
Shareholder Shares
1. Aberforth Smaller Companies Trust plc 1,407,300
2. Aberforth UK Small Companies Fund 1,269,900
3. The Church Commissioners for England 240,200
4. Aberforth Geared Capital & Income Trust plc 193,700
1,2,4 - registered in the name of Nortrust Nominees Ltd a/c Aberfrth,
3 - The Church Commissioners for England (Chase GIS) Nominees Ltd
5. Date of transaction (and date on which the threshold is crossed or reached
if different):
03/09/2007
6. Date on which issuer notified:
04/09/2007
7. Threshold(s) that is/are crossed or reached:
12%
8. Notified Details:
A: Voting rights attached to shares
Class/type of shares Situation previous to
if possible use the Triggering transaction
ISIN CODE
Number of shares Number of voting Rights
Ordinary 2,811,500 2,811,500
GB0006640972
Resulting situation after the triggering transaction
Class/type of shares Number of shares Number of voting rights % of voting rights
if possible use
ISIN CODE Direct Indirect Direct Indirect
Ordinary 3,111,100 N/A 3,111,100 N/A 12.25
GB0006640972
B: Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration date Exercise/conversion No. of voting % of voting
financial period/date rights that may rights
instrument be acquired (if
the instrument
exercised/
converted)
N/A N/A N/A N/A N/A
Total (A+B)
Number of voting rights % of voting rights
3,111,100 12.25
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
Held by Aberforth Partners LLP
Proxy Voting:
10. Name of proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A
13. Additional information:
In addition, Aberforth Partners LLP is interested in a further 517,400 shares
although we do not have access to the voting rights of these shares. Aberforth
Partners LLP is, therefore, interested in a total of 3,628,500 shares of the
above company. This interest arises as a result of the discretionary investment
management powers that we can exercise over the funds of our clients, Aberforth
Partners LLP is not the beneficial owner of these shares.
14. Contact name:
David Holland, Aberforth Partners LLP
15. Contact telephone number:
0131 220 0733
For notes on how to complete form TR-1 please see the FSA website.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.